Datasets:
id int64 259 5.32k | question stringlengths 11 194 | gold_answer stringlengths 1 934 | paper_id stringclasses 137
values | gold_chunk_ids listlengths 0 82 | match stringclasses 3
values |
|---|---|---|---|---|---|
5,201 | What health regulations were changes due to the outbreak of C. burnetti? | forbid the display of sheep in the latter third of their pregnancy and require regular testing of animals for C. burnetii in petting zoos | pmc1618839 | [
"pmc1618839:c44"
] | exact |
5,202 | What was the median seropresence of C. burnetti in sheep flocks not linked to human outbreaks? | 1% | pmc1618839 | [
"pmc1618839:c2",
"pmc1618839:c3",
"pmc1618839:c4",
"pmc1618839:c5",
"pmc1618839:c6",
"pmc1618839:c9",
"pmc1618839:c10",
"pmc1618839:c11",
"pmc1618839:c13",
"pmc1618839:c14",
"pmc1618839:c16",
"pmc1618839:c23",
"pmc1618839:c24",
"pmc1618839:c25",
"pmc1618839:c26",
"pmc1618839:c27",
"p... | exact |
5,203 | What important risk factors to infection were found during the second case-controlled study? | close proximity to the ewe and duration of exposure | pmc1618839 | [
"pmc1618839:c40"
] | exact |
5,204 | What was the interquartile range of the incubation period? | 16 to 24 days | pmc1618839 | [
"pmc1618839:c40"
] | exact |
5,205 | How many controls were used in the second case study? | 36 | pmc1618839 | [
"pmc1618839:c2",
"pmc1618839:c14",
"pmc1618839:c24",
"pmc1618839:c27",
"pmc1618839:c28",
"pmc1618839:c38",
"pmc1618839:c50"
] | exact |
5,206 | What public event was linked with the outbreak? | farmers' market | pmc1618839 | [
"pmc1618839:c4",
"pmc1618839:c6",
"pmc1618839:c10",
"pmc1618839:c11",
"pmc1618839:c12",
"pmc1618839:c13",
"pmc1618839:c15",
"pmc1618839:c16",
"pmc1618839:c18",
"pmc1618839:c22",
"pmc1618839:c24",
"pmc1618839:c25",
"pmc1618839:c26",
"pmc1618839:c28",
"pmc1618839:c32",
"pmc1618839:c35",
... | exact |
5,207 | What causes Q fever? | Coxiella burnetii (C. burnetii) | pmc1618839 | [
"pmc1618839:c4",
"pmc1618839:c5"
] | exact |
5,208 | What is Coxiella burnetii? | small, gram-negative obligate intracellular bacterium | pmc1618839 | [
"pmc1618839:c5"
] | exact |
5,209 | What is the primary reservoir for Coxiella burnetii? | sheep, goat and cattle | pmc1618839 | [
"pmc1618839:c5"
] | exact |
5,210 | How are humans typically infected with Coxiella burnetii? | inhalation of contaminated aerosols from parturient fluids, placenta or wool | pmc1618839 | [
"pmc1618839:c5"
] | exact |
5,255 | What are the limitations of a deterministic model? | cannot reliably represent effects originating from stochasticity, from effects in small populations, or from heterogeneities | pmc1832202 | [
"pmc1832202:c10"
] | exact |
1,625 | What is the Hepatitis C virus? | enveloped, positive-stranded RNA virus | pmc1852297 | [
"pmc1852297:c5"
] | exact |
1,626 | How many people have persistent hepatitis C virus? | 170 million people worldwide | pmc1852297 | [
"pmc1852297:c5"
] | exact |
1,627 | What is the long-term risk of chronic hepatitis C infection? | cirrhosis and hepatocellular carcinoma | pmc1852297 | [
"pmc1852297:c5"
] | exact |
1,628 | What antiviral treatments are used for hepatitis C infection? | pegylated alpha-interferon and ribavirin | pmc1852297 | [
"pmc1852297:c5"
] | exact |
5,171 | When did lions first occupy Europe? | By Mid Pleistocene (,500,000 years ago) | pmc2572142 | [
"pmc2572142:c5"
] | exact |
5,172 | What was the purpose of this study? | to assess the evolutionary history of lion | pmc2572142 | [
"pmc2572142:c9"
] | exact |
5,285 | What was the goal of this study? | to explore the feasibility of DNA vaccination of poultry | pmc2657001 | [
"pmc2657001:c5"
] | exact |
5,286 | What is the conclusion of this study? | it is possible to develop a multivalent DNA vaccine for poultry that can protect against multiple HPAI H5N1 strains and that could keep pace with the continued evolution of avian influenza viruses | pmc2657001 | [
"pmc2657001:c5"
] | exact |
2,175 | What is used by the Canadian Public Health System to identify periods of influenza activity? | weekly proportion of laboratory tests that are positive for influenza | pmc2722738 | [
"pmc2722738:c2"
] | exact |
2,176 | Why is laboratory confirmation of influenza infection not commonly performed? | diagnosis will often not alter patient management, a paucity of real-time, accurate, inexpensive testing methods [4] and because influenza is not recognized as the etiology of the clinical presentation | pmc2722738 | [
"pmc2722738:c3"
] | exact |
2,177 | What types of viral infections are monitored through Canada's Respiratory Virus Detection Surveillance System (RVDSS)? | nfluenza, respiratory syncytial virus (RSV), para-influenza virus (PIV), and adenovirus | pmc2722738 | [
"pmc2722738:c5"
] | exact |
262 | What is the main cause of HIV-1 infection in children? | Mother-to-child transmission (MTCT) is the main cause of HIV-1 infection in children worldwide. | pmc2752805 | [
"pmc2752805:c2"
] | exact |
276 | What plays the crucial role in the Mother to Child Transmission of HIV-1 and what increases the risk | DC-SIGNR plays a crucial role in MTCT of HIV-1 and that impaired placental DC-SIGNR expression increases risk of transmission. | pmc2752805 | [
"pmc2752805:c2"
] | exact |
278 | How many children were infected by HIV-1 in 2008-2009, worldwide? | more than 400,000 children were infected worldwide, mostly through MTCT and 90% of them lived in sub-Saharan Africa. | pmc2752805 | [
"pmc2752805:c5"
] | exact |
316 | What is the role of C-C Motif Chemokine Ligand 3 Like 1 (CCL3L1) in mother to child transmission of HIV-1? | High copy numbers of CCL3L1, a potent HIV-1 suppressive ligand for CCR5, are associated with higher chemokine production and lower risk of MTCT of HIV-1 among South African infants | pmc2752805 | [
"pmc2752805:c39"
] | exact |
305 | What is DC-GENR and where is it expressed? | Dendritic cell-specific ICAM-grabbing non-integrin-related (DC-SIGNR, also known as CD209L or liver/lymph node-specific ICAM-grabbing non-integrin (L-SIGN)) can interact with a plethora of pathogens including HIV-1 and is expressed in placental capillary endothelial cells | pmc2752805 | [
"pmc2752805:c5"
] | exact |
306 | How does the presence of DC-SIGNR affect the MTCT of HIV-1? | the presence of DC-SIGNR at the placental endothelial cell surface may protect infants from HIV-1 infection by capturing virus and promoting its degradation/presentation. | pmc2752805 | [
"pmc2752805:c39"
] | exact |
307 | Why do low levels of DC-SIGNR enhance Mother to Child Transmission of HIV-1? | in placenta containing low levels of DC-SIGNR, HIV-1 would preferentially binds CCR5 on endothelial cells resulting in a loss of placental barrier integrity and enhanced passage of maternal HIV-1-infected cells in foetal circulation leading to MTCT of HIV-1 | pmc2752805 | [
"pmc2752805:c39"
] | fuzzy |
277 | What is the percentage of Mother to Child Transmission of HIV-1, when there is no intervention? | Without specific interventions, the rate of HIV-1 mother-tochild transmission (MTCT) is approximately 15-45% | pmc2752805 | [
"pmc2752805:c5"
] | exact |
312 | Does C-C chemokine receptor type 5 (CCR5) affect the transmission of HIV-1? | Genetic variants in CCR5 have been shown to influence vertical transmission of HIV-1. CCR5 promoter variants resulting in higher expression of the receptor were associated with increased risk of MTCT of HIV-1 among sub-Saharan Africans | pmc2752805 | [
"pmc2752805:c39"
] | fuzzy |
318 | How does Mannanose Binding Lectin (MBL) affect elimination of HIV-1 pathogen? | Mannose-binding lectin (MBL) is an innate immune receptor synthesised in the liver and secreted in the bloodstream in response to inflammation signal. MBL promotes pathogen elimination by opsonization and phagocytosis, | pmc2752805 | [
"pmc2752805:c39"
] | exact |
321 | How can CCR5's effect in HIV-1 transmission be reduced? | The 32-pb deletion polymorphism in CCR5 has be shown to protect from vertical transmission of HIV-1 | pmc2752805 | [
"pmc2752805:c39"
] | exact |
887 | What is critical to the development of a protective granuloma in tuberculosis infections? | tumor necrosis factor-α | pmc2804704 | [
"pmc2804704:c2",
"pmc2804704:c36",
"pmc2804704:c39",
"pmc2804704:c42"
] | exact |
888 | What is tumor necrosis factor-alpha? | cytokines | pmc2804704 | [
"pmc2804704:c2",
"pmc2804704:c3",
"pmc2804704:c7",
"pmc2804704:c40"
] | exact |
889 | What regulates the activity of MAPK activity? | MAPK phosphatase-1 | pmc2804704 | [
"pmc2804704:c2",
"pmc2804704:c40"
] | exact |
890 | What causes tuberculosis? | Mycobacterium tuberculosis | pmc2804704 | [
"pmc2804704:c2",
"pmc2804704:c3",
"pmc2804704:c36",
"pmc2804704:c39"
] | exact |
891 | What percentage of the world has been infected by tuberculosis? | one third of the world's population | pmc2804704 | [
"pmc2804704:c3"
] | exact |
892 | How many new tuberculosis cases are there each year worldwide? | 9.2 million | pmc2804704 | [
"pmc2804704:c3"
] | exact |
893 | What are some mitogen activated protein kinases? | extracellular signal-regulated kinase 1 and 2 (ERK1/2), p38 MAPK, and c-Jun N-terminal kinase (JNK) | pmc2804704 | [
"pmc2804704:c3"
] | exact |
894 | How is MAPK activated? | phosphorylation | pmc2804704 | [
"pmc2804704:c4",
"pmc2804704:c6",
"pmc2804704:c7",
"pmc2804704:c19",
"pmc2804704:c20",
"pmc2804704:c21",
"pmc2804704:c22",
"pmc2804704:c23",
"pmc2804704:c41"
] | exact |
895 | What enzymes are involved with phosphorylation? | tyrosine phosphatases, serine/threonine phosphatases, and dual-specificity phosphatases (DUSPs) | pmc2804704 | [
"pmc2804704:c4"
] | exact |
896 | How many MAPK phosphatases exist? | at least 10 | pmc2804704 | [
"pmc2804704:c4"
] | exact |
897 | What is lipopolysaccharide? | a cell wall component of Gram-negative bacteria | pmc2804704 | [
"pmc2804704:c4"
] | exact |
898 | What is Staph aureus? | Gram positive bacteria | pmc2804704 | [
"pmc2804704:c5",
"pmc2804704:c40"
] | exact |
899 | What protein is in the critical path of immunity and cytokine expression? | MAPK | pmc2804704 | [
"pmc2804704:c2",
"pmc2804704:c3",
"pmc2804704:c4",
"pmc2804704:c6",
"pmc2804704:c7",
"pmc2804704:c12",
"pmc2804704:c15",
"pmc2804704:c19",
"pmc2804704:c20",
"pmc2804704:c21",
"pmc2804704:c22",
"pmc2804704:c23",
"pmc2804704:c24",
"pmc2804704:c25",
"pmc2804704:c33",
"pmc2804704:c36",
"... | exact |
2,477 | What is CHIKV marked by? | severe joint pain, contorting its victims into unusual postures | pmc2860491 | [
"pmc2860491:c2"
] | exact |
2,471 | What does Chikungunya cause? | fever disease, headache, rash, nausea, vomiting, myalgia, and arthralgia | pmc2860491 | [
"pmc2860491:c1"
] | exact |
2,470 | What is Chikungunya virus? | a mosquito-borne emerging pathogen | pmc2860491 | [
"pmc2860491:c1"
] | exact |
2,472 | Is there a treatment? | Currently, there is no vaccine or antiviral treatmen | pmc2860491 | [
"pmc2860491:c1"
] | exact |
2,473 | What conclusion is drawn in this report? | With the threat of an emerging global pandemic, the peculiar problems associated with the more immediate and seasonal epidemics warrant the development of an effective vaccine. | pmc2860491 | [
"pmc2860491:c1"
] | exact |
2,474 | What is Chikungunya virus? | a mosquito-borne pathogen listed by National Institute of Allergy and Infectious Diseases (NIAID) as a Category C Priority Pathogen that causes Chikungunya fever (CHIKF) | pmc2860491 | [
"pmc2860491:c2"
] | exact |
2,475 | What is CHIKV? | an arthropod-borne virus (arbovirus | pmc2860491 | [
"pmc2860491:c2"
] | exact |
2,476 | How is CHIKV propagated to humans? | primarily by Aedes aegypti, the infamous yellow fever propagator | pmc2860491 | [
"pmc2860491:c2"
] | exact |
2,478 | From what language the disease gets its name? | Kimakonde vernacular language of Tanzania and Mozambique | pmc2860491 | [
"pmc2860491:c2"
] | exact |
2,479 | What is the word Chikungunya mean? | 'that which contorts or bends up' | pmc2860491 | [
"pmc2860491:c2"
] | exact |
2,480 | What does Chikungunya mean in Swahili? | the illness of the bended walker | pmc2860491 | [
"pmc2860491:c2"
] | exact |
2,481 | How is CHIKV maintained in Africa? | in a sylvatic cycle among forest-dwelling Aedes spp. mosquitoes, wild primates, squirrels, birds, and rodents | pmc2860491 | [
"pmc2860491:c2"
] | exact |
2,482 | What is it vectored by, in Asia? | Ae. aegypti and Ae. albopictus | pmc2860491 | [
"pmc2860491:c2",
"pmc2860491:c8"
] | exact |
2,483 | How does the transmission in Asia occur? | in an urban cycle whereby the mosquito spreads the disease from an infected human to an uninfected human, following an epidemiological pattern similar to dengue fever | pmc2860491 | [
"pmc2860491:c2"
] | exact |
2,484 | What spurred the discovery of the new vector Ae. albopictus? | The 2005-2006 epidemic of CHIKV in La Reunion islands in the Indian Ocean, | pmc2860491 | [
"pmc2860491:c2"
] | exact |
2,485 | In the epidemic peak how many cases per week were there on the island? | 46,000 | pmc2860491 | [
"pmc2860491:c2"
] | exact |
2,486 | What does this review detail? | the epidemiology and global expansion of CHIKV | pmc2860491 | [
"pmc2860491:c2"
] | exact |
2,487 | What dose this review describe? | its clinical features and pathogenesis and its symptoms and complications, and finally nominates a possible vaccine approach against CHIKV infection. | pmc2860491 | [
"pmc2860491:c2"
] | exact |
2,488 | How many genotypes of CHIKV have been isilated? | three genotypes based on phylogenetic studies. | pmc2860491 | [
"pmc2860491:c3"
] | exact |
2,489 | What are the genotypes based on? | the gene sequences of an Envelope protein (E1), are Asian, East/Central/ South African, and West African | pmc2860491 | [
"pmc2860491:c3"
] | exact |
2,490 | hen did Asian genotype emerge? | between 50 and 310 y ago, | pmc2860491 | [
"pmc2860491:c3"
] | exact |
2,491 | When didthe Asian genotype diverge from African genotype? | between 100 and 840 y ago | pmc2860491 | [
"pmc2860491:c3"
] | exact |
2,492 | What is the status of Asian CHIKV since its emergence? | has come a long way, with several mutations incorporated, and has continued to wreak epidemics in several regions | pmc2860491 | [
"pmc2860491:c3"
] | exact |
2,493 | What are the recent activities of CHIKV? | the Indian epidemic in 2005-2006, which was followed by a sudden explosion of cases in 2007. An estimated 1.3 million people across 13 states were reported to be infected in India [12, 16] , and CHIKV was also widespread in Malaysia, Sri Lanka, and Indonesia [17] . In July-August of 2007, CHIKV was reported in Italy, ... | pmc2860491 | [
"pmc2860491:c3"
] | fuzzy |
2,494 | How was the Italian isolation found to have evolved from? | from the Kerala isolate, which was associated with a A226V shift in E1 gene that represents a successful evolutionary adaptation in the mosquito vector similar to the ones observed in Reunion Island [ | pmc2860491 | [
"pmc2860491:c3"
] | exact |
2,495 | How many days is the incubation period? | 2-6 d | pmc2860491 | [
"pmc2860491:c5"
] | exact |
2,496 | In how many days do the symptoms arise? | 4-7 | pmc2860491 | [
"pmc2860491:c5",
"pmc2860491:c24"
] | exact |
2,497 | What are exhibited in the two phases? | The first stage is acute, while the second stage, experienced by most but not all, is persistent, causing disabling polyarthritis. Characteristics of the acute phase include an abrupt onset of fever, arthralgia, and in some cases, maculopapular rash [6, 23] . The acute phase causes such intense joint and muscular pain ... | pmc2860491 | [
"pmc2860491:c5"
] | exact |
2,498 | What are consequences of infection? | Ninety-five percent of infected adults are symptomatic after infection, and of these, most become disabled for weeks to months as a result of decreased dexterity, loss of mobility, and delayed reaction. | pmc2860491 | [
"pmc2860491:c5"
] | exact |
2,499 | What percentage of the patients still have the CHIKV IgM after eighteen months? | The chronic stage of CHIKF is characterized by | pmc2860491 | [
"pmc2860491:c5"
] | exact |
2,500 | What is te chronic stage characterized by? | by polyarthralgia that can last from weeks to years beyond the acute stage | pmc2860491 | [
"pmc2860491:c5"
] | exact |
2,501 | What is affected by CHIKV? | fibroblasts | pmc2860491 | [
"pmc2860491:c5"
] | exact |
2,502 | What explains the pain associated with CHIKV? | The high number of nociceptive nerve endings found within the joints and muscle connective tissues | pmc2860491 | [
"pmc2860491:c5"
] | exact |
2,503 | What percentage of people suffering from the CHIKF are over 65 years old? | 50% | pmc2860491 | [
"pmc2860491:c3",
"pmc2860491:c5",
"pmc2860491:c9",
"pmc2860491:c15",
"pmc2860491:c16",
"pmc2860491:c21",
"pmc2860491:c27",
"pmc2860491:c29"
] | exact |
2,504 | What percentage die? | 33% | pmc2860491 | [
"pmc2860491:c5",
"pmc2860491:c9",
"pmc2860491:c21",
"pmc2860491:c26",
"pmc2860491:c27",
"pmc2860491:c30"
] | exact |
2,505 | What other group is disproportionately affected? | children | pmc2860491 | [
"pmc2860491:c5"
] | exact |
2,506 | What complications are associated with CHIKV? | from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure | pmc2860491 | [
"pmc2860491:c5"
] | exact |
2,507 | What happens after host infection? | CHIKV undertakes a complex replication cycle upon host infection (Figure 2 ), which makes its genome susceptible to mutations | pmc2860491 | [
"pmc2860491:c6"
] | exact |
2,508 | What did the Ae.Aegypti which is responsible for epidemics in Kenya, Comoros and Seychelles carry? | CHIKV with an alanine in the 226 position of the E1 gene (E1-A226) | pmc2860491 | [
"pmc2860491:c6"
] | exact |
2,509 | what was the result of the decline in population of Ae. Aegyptus when the virus struck the Reunion Islands, due to massive use dichlorodiphenyltrichloroethane usage? | in an ecological pressure, favoring replacement of alanine at position 226 with valine (E1-A226V) | pmc2860491 | [
"pmc2860491:c6"
] | exact |
2,510 | What did this mutation allow? | CHIKV's secondary vector species, Ae. albopictus, to supplement Ae. aegypti as its primary vector | pmc2860491 | [
"pmc2860491:c6"
] | exact |
2,511 | What vectored the large epidemic in La Reunion Islands? | Ae. albopictus | pmc2860491 | [
"pmc2860491:c2",
"pmc2860491:c5",
"pmc2860491:c6",
"pmc2860491:c7",
"pmc2860491:c8"
] | exact |
2,512 | What percentage of population was affected? | 34% | pmc2860491 | [
"pmc2860491:c7",
"pmc2860491:c9",
"pmc2860491:c24",
"pmc2860491:c27",
"pmc2860491:c29",
"pmc2860491:c30"
] | exact |
2,513 | Where were the CHIKV strain found? | All of the CHIKV strains isolated from Mayotte carried the E1-A226V mutation, and the mutation was also found in Madagascar in 2007 [ | pmc2860491 | [
"pmc2860491:c7"
] | fuzzy |
2,514 | What is the finding on E1-A226V in Indian Ocean? | mutation was not present at the beginning of the Indian Ocean Islands outbreak (before September 2005). However, more than 90% of later viral strains found there had incorporated the mutation (December-March 2006), indicating a genotype switch during the winter season | pmc2860491 | [
"pmc2860491:c7"
] | exact |
2,515 | What has the E1-A226V enabled? | an increase in infectivity of Ae. albopictus when compared to its infectivity of Ae. aegypti | pmc2860491 | [
"pmc2860491:c7"
] | exact |
2,516 | What has become the preferred and lethal vector? | Ae. albopictus | pmc2860491 | [
"pmc2860491:c2",
"pmc2860491:c5",
"pmc2860491:c6",
"pmc2860491:c7",
"pmc2860491:c8"
] | exact |
2,517 | What was the finding on the Green Fluorescent tagged E1-A226V? | E1-A226V virus was 100 times more infective to Ae. albopictus than it was to Ae. aegypti | pmc2860491 | [
"pmc2860491:c7"
] | exact |
2,518 | What became the main vector in the Indian Ocean within 1-2 y after CHIKV was introduced? | Ae. albopictus | pmc2860491 | [
"pmc2860491:c2",
"pmc2860491:c5",
"pmc2860491:c6",
"pmc2860491:c7",
"pmc2860491:c8"
] | exact |
2,519 | how long Ae. aegypti been established in North America? | for over 300 | pmc2860491 | [
"pmc2860491:c8"
] | exact |
2,520 | What is the presence of Ae.albopictus in North America? | has been in many areas of the US, since 1985, primarily in Florida [32] and since then has expanded its range in the country. | pmc2860491 | [
"pmc2860491:c8"
] | exact |
2,521 | What percentage of newborns were infected from their mother? | 50% | pmc2860491 | [
"pmc2860491:c3",
"pmc2860491:c5",
"pmc2860491:c9",
"pmc2860491:c15",
"pmc2860491:c16",
"pmc2860491:c21",
"pmc2860491:c27",
"pmc2860491:c29"
] | exact |
2,522 | What has been some instances of mother to fetus transmission? | congenital illness and fetal death | pmc2860491 | [
"pmc2860491:c9"
] | exact |
2,523 | What did the studies reveal regarding transmission from mothers during perinatal period? | During the 2005-2006 La Reunion Island outbreaks, Ramful et al. discovered that mothers could transmit CHIKV to their progeny during the perinatal period (Day 24 to Day +1) [33, 34] , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting ... | pmc2860491 | [
"pmc2860491:c9"
] | fuzzy |
COVID-QA Retrieval Benchmark — parsed with the AnacodicAI guidelines pipeline
A public retrieval / RAG benchmark over biomedical COVID-19 papers. Questions and gold answers come from deepset COVID-QA (Apache-2.0); the papers were fetched as PDFs and parsed with the same production pipeline as the AnacodicAI guidelines-generator and specialistRAG systems — so a number here reflects the real pipeline, not a toy one.
- 1,637 papers total: 137 with questions + 1,500 topic-matched decoys (hard negatives, no questions)
- 1,852 questions with marked gold answer spans
- Every answer is a span of its article, so standard IR metrics apply: Recall@k, nDCG@k, context recall/precision, faithfulness.
What's in here
| File | What it is | Start here if you are… |
|---|---|---|
gold/questions.jsonl |
question, gold_answer, paper_id, gold_chunk_ids, match (1,852 rows) |
computing metrics (everyone) |
chunks.jsonl |
64,965 production chunks for all 1,637 papers — chunk_id, paper_slug, chunk_type, section_path, pages, text, embed_text, … |
scoring retrieval (fixed chunking) |
parsed_questions_137.tar.zst |
the 137 papers that have questions (.docling.json + assets) — 1.7 GB download, ~2.6 GB unpacked |
comparing chunkers — start here (Task 1) |
parsed_decoys_1500.tar.zst |
the 1,500 decoy papers (no questions), same format — 17 GB download | add these for the hard setting (Task 2) |
parsed_all_1637.tar.zst |
both of the above in one archive — 18 GB download, 32 GB unpacked | if you want everything at once |
manifest.csv |
the 147 COVID-QA articles: PMC ID, DOI, licence, fetch status | provenance |
manifest_distractors.csv |
the decoys: PMC ID, DOI, title, licence, fetch status | provenance |
All three archives unpack to the same layout, 02_parsed/covidqa/<paper>/, so
parsed_questions_137 + parsed_decoys_1500 = parsed_all_1637.
Production chunker (identical to guidelines-generator / specialistRAG): Docling
HybridChunker · 512 tokens · tiktoken for text-embedding-3-large ·
repeat_table_header · merge_peers · always_emit_headings · contextualize.
Two scoring rules that matter
gold_chunk_idsfit the 512-token production chunks only. If you re-chunk (256, 1024, a different splitter), score "does a top-k chunk contain the gold answer text" with a text match — not chunk IDs.match = noneflags answers the parse lost (~1%). Report it; part of it is COVID-QA's own OCR noise (e.g.32uCfor32 °C).
Quick start
from huggingface_hub import hf_hub_download
import json
qpath = hf_hub_download("anacodicai-labs/covidqa-bench", "gold/questions.jsonl", repo_type="dataset")
cpath = hf_hub_download("anacodicai-labs/covidqa-bench", "chunks.jsonl", repo_type="dataset")
questions = [json.loads(l) for l in open(qpath)]
chunks = [json.loads(l) for l in open(cpath)]
Unpack the parsed papers (for re-chunking) — start with the 137 question papers:
hf download anacodicai-labs/covidqa-bench parsed_questions_137.tar.zst --repo-type dataset --local-dir .
tar -I zstd -xf parsed_questions_137.tar.zst # → 02_parsed/covidqa/<paper>/
# later, for the hard setting, add the decoys into the same folder:
hf download anacodicai-labs/covidqa-bench parsed_decoys_1500.tar.zst --repo-type dataset --local-dir .
tar -I zstd -xf parsed_decoys_1500.tar.zst
Licence & attribution
- Questions/answers: deepset COVID-QA, Apache-2.0.
- Papers: CC0 / CC BY only, each under its own licence — see
manifest.csv(question papers) andmanifest_distractors.csv(decoys). 10 COVID-QA articles without a redistributable PDF were excluded; retracted papers were skipped. - Source acknowledgement: NIH NLM NCBI PubMed Central (PMC) Article Datasets, accessed via https://registry.opendata.aws/ncbi-pmc. This dataset is not endorsed by NLM / NIH.
Maintainers
Curated by Rashan (@rashanbu) at AnacodicAI Labs.
- Downloads last month
- 143